Australia - English - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - calcipotriol, quantity: 50 microgram/g - ointment - excipient ingredients: disodium edetate; dibasic sodium phosphate dihydrate; dl-alpha-tocopherol; liquid paraffin; steareth-2; propylene glycol; purified water; white soft paraffin - calcipotriol ointment is indicated for the topical treatment of chronic stable plaque type psoriasis vulgaris in adult patients. indications as at 26 march 2002: daivonex ointment is indicated for the topical treatment of chronic stable plaque type psoriasis vulgaris in adults and children (see use in children). in adult patients, daivonex ointment may also be used in combination with either phototherapy, or systemic acitretin or cyclosporin.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - mometasone furoate, quantity: 1 mg/g - ointment - excipient ingredients: white soft paraffin; propylene glycol monostearate; purified water; hexylene glycol; white beeswax; phosphoric acid - the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as psoriasis & atopic dermatitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - povidone-iodine, quantity: 100 mg/g (equivalent: iodine, qty 10 mg/g) - ointment - excipient ingredients: sodium bicarbonate; macrogol 1000; macrogol 3350; macrogol 400; purified water; macrogol 1500 - for the treatment of common skin infections. e.g. infections of the skin around the nails, cold sores and prevention of infections in minor burns, cuts and abrasions. betadine antiseptic ointment is a bactericidal antiseptic.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

phoenix healthcare distribution ltd - magnesium sulfate dried; phenoxyethanol; wool alcohols ointment - cutaneous ointment - 5mg/1gram ; 10mg/1gram ; 500mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - magnesium sulfate dried; phenoxyethanol; wool alcohols ointment - cutaneous ointment - 5mg/1gram ; 10mg/1gram ; 500mg/1gram

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - prednisolone hexanoate, quantity: 1.9 mg/g; cinchocaine hydrochloride, quantity: 5 mg/g - ointment - excipient ingredients: hydrogenated castor oil; octyldodecanol; peg-8 ricinoleate; castor oil; fragrance (perfume) - symptomatic relief of pain and irritation associated with haemorrhoids, superficial anal fissures and proctitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nystatin, quantity: 100000 u/g; triamcinolone acetonide, quantity: 1 mg/g; gramicidin, quantity: 0.25 mg/g; neomycin sulfate (equivalent: neomycin, qty 2.5 mg/g) - ointment - excipient ingredients: liquid paraffin; polyethylene - otocomb otic is indicated for the treatment of otitis externa (acute and chronic) when a topical corticosteroid is required and active infections with susceptible organisms are either present or likely to supervene.

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - hydrocortisone, quantity: 5 mg/g; cinchocaine hydrochloride, quantity: 5 mg/g - ointment - excipient ingredients: wool fat; white soft paraffin; liquid paraffin - for the symptomatic relief of external and internal haemorrhoids, anal pruritus, anal fissure. pre and post-operative treatment of haemorrhoidectomy patients. post-partum haemorrhoidal conditions. non-infective proctitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - mupirocin calcium, quantity: 21.5 mg/g (equivalent: mupirocin, qty 20 mg/g) - ointment - excipient ingredients: white soft paraffin; bis-diglyceryl polyacyladipate-2 - bactroban (mupirocin) nasal ointment is indicated for the elimination of nasal carriage of staphylococci including methicillin resistant staphylococcus aureus (mrsa).

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - crisaborole, quantity: 2 % w/w - ointment - excipient ingredients: glyceryl monostearate; butylated hydroxytoluene; sodium calcium edetate; synthetic paraffin; white soft paraffin; propylene glycol - staquis is indicated for topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older